All Stories

  1. Peptide-Pulsed Dendritic Cell Vaccination Confers Protection Response Against Paracoccidioides lutzii in an Experimental Model
  2. The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets
  3. Galleria mellonella as an Invertebrate Model for Studying Fungal Infections
  4. Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes
  5. Saps1–3 Antigens in Candida albicans: Differential Modulation Following Exposure to Soluble Proteins, Mammalian Cells, and Infection in Mice
  6. Proceedings of the second international meeting on endemic mycoses of the Americas (IMEMA) and first international symposium on implantation mycoses (ISIM)
  7. Towards a Better Understanding of Melanins from Dark Septate Endophytes (DSEs): Their Variability, Synthesis Pathways and Biological Roles
  8. Human interleukin-36γ plays a crucial role in cytokine induction during Sporothrix brasiliensis and S. schenckii infection in keratinocytes and PBMCs
  9. Use of 2D minilungs from human embryonic stem cells to study the interaction of Cryptococcus neoformans with the respiratory tract
  10. First occurrence of feline sporotrichosis in a metropolitan area of Central-West Brazil
  11. Skin innate immune response against fungal infections and the potential role of trained immunity
  12. Vaccine development for pathogenic fungi: current status and future directions
  13. Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis
  14. The story of Paracoccidiodes gp43
  15. Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
  16. Editorial: Tropical fungal diseases
  17. Humicolopsis cephalosporioides synthesizes DHN-melanin in its chlamydospores
  18. In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.
  19. Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential
  20. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. Schenckii
  21. Minilungs from Human Embryonic Stem Cells to Study the Interaction of Streptococcus pneumoniae with the Respiratory Tract
  22. Minilungs from hESCs to study the interaction ofStreptococcus pneumoniaewith the respiratory tract
  23. Differential recognition and cytokine induction by the peptidorhamnomannan from Sporothrix brasiliensis and S. schenckii
  24. Application of Nanoparticles to Invasive Fungal Infections
  25. Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis
  26. Immunoproteomic and Immunopeptidomic Analyses of Histoplasma capsulatum Reveal Promiscuous and Conserved Epitopes Among Fungi With Vaccine Potential
  27. Editorial: Pathogenesis of Dimorphic Fungal Infections
  28. The influence of sample processing time on the performance ofMicrosporum caniscultures in cats
  29. Antibody- Based Immunotherapy Combined With Antimycotic Drug TMP- SMX to Treat Infection With Paracoccidioides brasiliensis
  30. Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches
  31. Neutrophil Cells Are Essential for The Efficacy of a Therapeutic Vaccine against Paracoccidioidomycosis
  32. Identification of Potentially Therapeutic Immunogenic Peptides From Paracoccidioides lutzii Species
  33. Generation and Activity Evaluation of a Mouse-Human Immunoglobulin G1 Chimeric Antibody to Histoplasma capsulatum HSP60
  34. In Vitro and In Vivo Effect of Peptides Derived from 14-3-3 Paracoccidioides spp. Protein
  35. Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis
  36. Melanin as a Virulence Factor in Different Species of Genus Paracoccidioides
  37. In vivo Activity of Silver Nanoparticles Against Pseudomonas aeruginosa Infection in Galleria mellonella
  38. In Vitro and In Vivo Inhibitory Activity of Limonene against Different Isolates of Candida spp.
  39. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections
  40. Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model
  41. Advances in Fungal Peptide Vaccines
  42. Pathogenicity Levels of Colombian Strains of Candida auris and Brazilian Strains of Candida haemulonii Species Complex in Both Murine and Galleria mellonella Experimental Models
  43. Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies
  44. A comment on “First report of tinea corporis caused by Arthroderma benhamiae in Brazil”
  45. The secreted acid trehalase encoded by the CgATH1 gene is involved in Candida glabrata virulence
  46. Comparison of carpet and toothbrush techniques for the detection of Microsporum canis in cats
  47. Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice
  48. Unravelling the nature of the spongy dark material in aged Turkevich gold nanoparticles colloidal solutions by CytoViva® dark-field imaging and HRTEM analysis
  49. Vaccine Development to Systemic Mycoses by Thermally Dimorphic Fungi
  50. Molecular detection of Histoplasma capsulatum indoors: A public health approach
  51. Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages
  52. Paracoccidioides spp. and Histoplasma capsulatum: Current and New Perspectives
  53. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment
  54. Esporotricose - gato como fonte de infecção em foco epidêmico familiar em Guarulhos, São Paulo: relato de caso
  55. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection
  56. Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier
  57. Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
  58. Antifungal Activity of the Biphosphinic Cyclopalladate C7a against Candida albicans Yeast Forms In Vitro and In Vivo
  59. Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation
  60. Development of enzyme immunoassays (ELISA and Western blot) for the serological diagnosis of dermatophytosis in symptomatic and asymptomatic cats
  61. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates
  62. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi
  63. Peptide Vaccine Against Paracoccidioidomycosis
  64. Celebration of 60th anniversary of Brazilian Society for Microbiology
  65. Peptidorhamnomannan negatively modulates the immune response in a scedosporiosis murine model
  66. Identification and Analysis of the Role of Superoxide Dismutases Isoforms in the Pathogenesis of Paracoccidioides spp.
  67. Antibodies Against Glycolipids Enhance Antifungal Activity of Macrophages and Reduce Fungal Burden After Infection with Paracoccidioides brasiliensis
  68. Isolation of Dermatophytes from the Hair Coat of Healthy Persian Cats without Skin Lesions from Commercial Catteries Located in São Paulo Metropolitan Area, Brazil
  69. SENSIBILIDADE DO LAMINOCULTIVO DERMATOBAC® PARA O DIAGNÓSTICO DA ENDOMETRITE FÚNGICA EM ÉGUAS
  70. Macrophage Interaction with Paracoccidioides brasiliensis Yeast Cells Modulates Fungal Metabolism and Generates a Response to Oxidative Stress
  71. PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
  72. Dendritic cell interactions withHistoplasmaandParacoccidioides
  73. 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents
  74. Influence of melaleuca and copaiba oils onCandida albicansadhesion
  75. Serological Diagnosis of Paracoccidioidomycosis: High Rate of Inter-laboratorial Variability among Medical Mycology Reference Centers
  76. Monoclonal antibodies to heat shock protein 60 induce a protective immune response against experimental Paracoccidioides lutzii
  77. Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis
  78. Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties
  79. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis
  80. Erratum to: Isolation of Sporothrix schenckii From the Claws of Domestic Cats (Indoor and Outdoor) and in Captivity in São Paulo (Brazil)
  81. DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells
  82. Galleria mellonellaas a model host to studyParacoccidioides lutziiandHistoplasma capsulatum
  83. Vaccines and immunotherapy against fungi: the new frontier
  84. Paracoccidioidomycosis vaccine
  85. Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
  86. New advances in the development of a vaccine against paracoccidioidomycosis
  87. The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide
  88. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis
  89. Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensis
  90. Isolation of Histoplasma capsulatum from bats in the urban area of São Paulo State, Brazil
  91. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii
  92. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus
  93. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis
  94. Identification and characterization of antigenic proteins potentially expressed during the infectious process of Paracoccidioides brasiliensis
  95. Antifungal and antitumor models of bioactive protective peptides
  96. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18
  97. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006
  98. Paracoccidioides brasiliensis Vaccine Formulations Based on the gp43-Derived P10 Sequence and the Salmonella enterica FliC Flagellin
  99. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis
  100. In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis
  101. Glycoconjugates and polysaccharides of fungal cell wall and activation of immune system
  102. The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB/c Mice Challenged Intratracheally with the Fungus
  103. Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy
  104. Melanin as a virulence factor of Paracoccidioides brasiliensis and other dimorphic pathogenic fungi: a minireview
  105. Treatment options for paracoccidioidomycosis and new strategies investigated
  106. Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound fromAllium sativum, associated with sulfamethoxazole/trimethoprim
  107. Peptide Immunization as an Adjuvant to Chemotherapy in Mice Challenged Intratracheally with Virulent Yeast Cells of Paracoccidioides brasiliensis
  108. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility
  109. Synthesis and Immunological Activity of a Branched Peptide Carrying the T-cell Epitope of gp43, the Major Exocellular Antigen of Paracoccidioides brasiliensis
  110. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3-mediated interactions
  111. More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG
  112. Superoxide Dismutase Influences the Virulence of Cryptococcus neoformans by Affecting Growth within Macrophages
  113. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans
  114. Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3
  115. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
  116. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
  117. Immunoglobulin M Efficacy AgainstCryptococcus neoformans: Mechanism, Dose Dependence, and Prozone-Like Effects in Passive Protection Experiments
  118. PCR for Diagnosis of Paracoccidioidomycosis
  119. Evaluation of the INNO-LIA HTLV I/II Assay for Confirmation of Human T-Cell Leukemia Virus-Reactive Sera in Blood Bank Donations
  120. Mapping of the T-Cell Epitope in the Major 43-Kilodalton Glycoprotein ofParacoccidioides brasiliensisWhich Induces a Th-1 Response Protective against Fungal Infection in BALB/c Mice
  121. Monoclonal antibody capture enzyme immunoassay for detection of Paracoccidioides brasiliensis antibodies in paracoccidioidomycosis
  122. Diagnosis of paracoccidioidomycosis by dot immunobinding assay for antibody detection using the purified and specific antigen gp43
  123. Antigenic relationship betweenParacoccidioides brasiliensisisolated from faeces of a penguin and a human isolate ofP. brasiliensis
  124. Diagnosis of paracoccidioidomycosis by passive haemagglutination assay of antibody using a purified and specific antigen-gp43
  125. The use of cell-free antigens ofParacoccidioides brasiliensisin serological tests